SERUM CREATINE KINASE AND CREATININE LEVELS AND CLINICAL FEATURES IN PATIENT WITH SPINAL MUSCULAR ATROPHY UNDER TREATMENT WITH NUSINERSEN
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingCharacterization of Cellular Differentiation in an in vitro model of Neuromuscular Junction using a Co-Culture system: A Preliminary Study of a Drug Testing Platform
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingEmerin is involved in microtubule-organizing center (MTOC) relocalization to the nuclear surface: altered dynamics in type 1 Emery-Dreifuss Muscular Dystrophy
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingEngineering 3D Models to Investigate LGMDD2 Transportin 3 Related: Insights into Myogenic Processes and Contractile Dysfunction
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingThe CFTR corrector C17 as potential treatment for sarcoglycanopathies: pharmacology and efficacy in mouse
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingRecurrent respiratory infections in congenital myopathy due to mutation of PYROXD1
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingMyasthenia Gravis as part of the Graft-versus-host disease spectrum
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSeasonal Variation in Myasthenia Gravis Incidence
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingAssessing the phenotype and genotype of a wide Italian DM1 and DM2 cohort: results from the Italian Myotonic Dystrophies National Registry
/0 Commenti/in GRUPPO 1, servidei, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences